Paper6842003
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Wade JC and 5 others. J Infect Dis, 1983. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. Papers, record 6842003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6842003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Agranulocytosis | Major topic |
| Bacterial Infections | Major topic |
| Leukemia | Major topic |
| Nalidixic Acid | Major topic |
| Sulfamethizole | Major topic |
| Sulfathiazoles | Major topic |
| Trimethoprim | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Drug Combinations | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Mycoses | |
| Nystatin | |
| Patient Compliance | |
| Prospective Studies | |
| Random Allocation | |
| Benzenesulfonamides |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22258955 | Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22258955 | PubMed |
| 15227389 | Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions. | Tex Heart Inst J | 1990 | https://conductscience.org/library/papers/15227389 | PubMed |
| 9227863 | Antifungal prophylaxis during neutropenia and immunodeficiency. | Clin Microbiol Rev | 1997 | https://conductscience.org/library/papers/9227863 | PubMed |
| 8460916 | Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8460916 | PubMed |
| 8156265 | Salmonella infections in a cancer center. | Support Care Cancer | 1994 | https://conductscience.org/library/papers/8156265 | PubMed |
| 3960694 | The place of quinolones in antibacterial therapy in hospitals. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3960694 | PubMed |
| 3729360 | Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3729360 | PubMed |
| 3666959 | Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. | Infect Immun | 1987 | https://conductscience.org/library/papers/3666959 | PubMed |
| 3549037 | Antibacterial therapy in patients with malignancies. | Cancer Metastasis Rev | 1987 | https://conductscience.org/library/papers/3549037 | PubMed |
| 3491791 | Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. | Infection | 1986 | https://conductscience.org/library/papers/3491791 | PubMed |
| 3481358 | Ofloxacin for prevention of bacterial infections in granulocytopenic patients. | Infection | 1987 | https://conductscience.org/library/papers/3481358 | PubMed |
| 3477669 | High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. | Klin Wochenschr | 1987 | https://conductscience.org/library/papers/3477669 | PubMed |
| 3325929 | Ciprofloxacin for infection prevention in patients with acute leukemia. | Pharm Weekbl Sci | 1987 | https://conductscience.org/library/papers/3325929 | PubMed |
| 3325435 | Hematological side effects of co-trimoxazole. | Infection | 1987 | https://conductscience.org/library/papers/3325435 | PubMed |
| 3325256 | Antimicrobial prophylaxis in immunocompromised patients. | Drugs | 1987 | https://conductscience.org/library/papers/3325256 | PubMed |
| 3312287 | Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3312287 | PubMed |
| 3300532 | Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3300532 | PubMed |
| 3132368 | Role of intestinal anaerobic bacteria in colonization resistance. | Eur J Clin Microbiol Infect Dis | 1988 | https://conductscience.org/library/papers/3132368 | PubMed |
| 3028964 | Bacteriological data on a prospective multicenter study of the effect of two different regimens for selective decontamination in patients with acute leukaemia. | Infection | 1986 | https://conductscience.org/library/papers/3028964 | PubMed |
| 2938072 | Quinolones and colonization resistance in human volunteers. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/2938072 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6842003
GET https://conductscience.org/api/papers/v1/6842003/cited_by?page=2